Susanna Edelstein v. HHS - Influenza, Guillain-Barre Syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP) (2020)

Susanna Edelstein filed a petition on March 6, 2019, alleging that an influenza vaccine and/or a tetanus-diphtheria-acellular pertussis (Tdap) vaccine administered on September 5, 2016, caused her to suffer Guillain-Barre Syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP). The respondent, the Secretary of Health and Human Services, denied that the vaccines caused the GBS or CIDP and denied that the condition was factually caused by the vaccines.

Despite these denials, the parties filed a joint stipulation recommending an award of compensation to Ms. Edelstein.

Special Master Nora Beth Dorsey reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. The stipulation provided for a lump sum award of $231,500.00, payable to Ms.

Edelstein, as compensation for all damages available under 42 U.S.C. § 300aa-15(a). The decision was based on this stipulation, and judgment was to be entered accordingly.

Edward M. Kraus represented the petitioner, and Ida Nassar represented the respondent.

The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert testimony.